Advanced glycation end products in renal failure: an overview.
The article aims to present an overview of the existing knowledge on advanced glycation end products (AGE). They are moieties that bind to proteins, but also lipids and nuclear acids. AGE are formed during glycation and oxidative stress. Accumulation of AGE occurs especially in diabetes and chronic renal failure and plays a major pathogenetic role. The deleterious effects of AGE result from cross-linking of proteins and activation of the receptor for advanced glycation end products. AGE accumulation can be noninvasively assessed by the skin autofluorescence reader. In diabetics, the skin autofluorescence predicts cardiac mortality and the occurrence of macro- and microvascular complications. In patients on haemodialysis, skin autofluorescence is highly elevated and predicts mortality. After renal transplantation AGE accumulation is lower than during haemodialysis, but still remains elevated and is a strong risk factor for chronic renal transplant dysfunction. Some of the potential methods to intervene with AGE accumulation are discussed in this article.
Noordzij
M J
MJ
Department of Internal Medicine, Division of Vascular Medicine, University Medical Center Groningen, University of Groningen, The Netherlands. m.j.noordzij@int.umcg.nl
Lefrandt
J D
JD
Smit
A J
AJ
D015415:Biomarkers / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy; D012867:Skin / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D016019:Survival Analysis
D015415:Biomarkers; D017127:Glycation End Products, Advanced